Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Sponsors and Collaborators
James M McKiernan, MD, Columbia University Medical Center, Urology
Next post in Bladder Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.